the United States will begin testing the treatment by the plasma without binding to a specific blood group. The President expressed the opinion that this method of treatment may be universal. The blood plasma of recovered patients will also be used to create drugs with a concentrated content of antibodies, which must not correspond to a specific blood group, said at a press briefing Donald trump.
“the same method can also be a prevention measure for everyone who is at risk. Clinical trials will begin in a few weeks”, – quotes the American leader TASS.
According to trump, in the development of vaccines, the authorities cooperate with other countries. At the same time in the USA now check out over 70 different methods of treatment for coronavirus. The researchers said that it is recommended to use the drug hydroxychloroquine has not proved its potential usefulness in the treatment of COVID-19. On the conclusion of experts told the Director of the Center for control and prevention of diseases of the USA Robert Redfield.
According to the Johns Hopkins University, which maintains statistics on the disease, a new virus in the United States infected 866 646 thousand people. All in all the world, this diagnosis was confirmed in 2 million 703 thousand 615 cases. The outbreak of the new virus was at the end of December 2019, in Central China, and already on March 11, the world health organization declared it a pandemic.